Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

514 public trials 240 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT06586957

Conditions
Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
Locations
  • University of Arkansas Medical School Little Rock, Arkansas, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
View all 19 locations
View Trial Details
Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

NCT06561685

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +21 more
Locations
  • UCLA Santa Monica, California, United States
  • University of Colorado Health Hospital Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
View all 33 locations
View Trial Details
Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

NCT06362369

Conditions
ALK Genomic Tumor Aberrations, Adenocarcinoma, Adenoma, +69 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Dartmouth Hitchcock Lebanon, New Hampshire, United States
  • Brown University Health Cancer Institute Providence, Rhode Island, United States
View Trial Details
Recruiting

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

NCT06487624

Conditions
Advanced Solid Tumor, Bone Diseases, Bone Diseases, Developmental, +15 more
Locations
  • Prisma Health-Upstate Greenville, South Carolina, United States
  • The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China
  • Zhejiang Provincial Cancer Hospital Hangzhou, China
  • Xuzhou Central Hospital Xuzhou, China
View Trial Details
Recruiting

First in Human Study of T3P-Y058-739 (T3P)

NCT05120596

Conditions
Advanced Solid Tumor, Neoplasms
Locations
  • Clinica Universidad de Navarra Pamplona, Navarre, Spain
  • Vall d'Hebron Institute of Oncology Barcelona, Spain
  • Institut Catala D'oncologia L'Hospitalet de Llobregat, Spain
  • Clinica Universidad de Navarra Madrid, Spain
View all 15 locations
View Trial Details
Recruiting

Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

NCT06635785

Conditions
Advanced Solid Tumor
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Florida UF Health Cancer Center Gainesville, Florida, United States
View all 19 locations
View Trial Details
Recruiting

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

NCT05785741

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCLA Hematology/Oncology - Santa Monica Santa Monica, California, United States
  • Research Site 117 Coral Gables, Florida, United States
  • D&H Cancer Research Center LLC Margate, Florida, United States
View all 24 locations
View Trial Details

Related conditions